Fibromyalgia Treatment Market is Expected to Reach $2.7 billion by 2033, with Anticonvulsants Accounting for 35% of the Market Share, According to Persistence Market Research New York, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market is expected to reach USD 2.7 billion by 2032, growing at a CAGR of 7.0% from 2023 to 2033. The growth of the...